In vivo study of mPEG–PCL as a nanocarriers for anti-inflammatory drug delivery of simvastatin-Reference-Cited by-同舟云学术

In vivo study of mPEG–PCL as a nanocarriers for anti-inflammatory drug delivery of simvastatin

Author:

Zamani Mostafa¹²^ORCID,Shirinzadeh Amin³,Aghajanzadeh Mozhgan¹²^ORCID,Andalib Sina⁴,Danafar Hossein⁵⁶⁷^ORCID

Affiliation:

1. Student Research Committee, Zanjan University of Medical Sciences, Zanjan, Iran;

2. Department of Pharmaceutical Biomaterials, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran;

3. School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran;

4. Zanjan Applied Pharmacology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran;

5. Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran;

6. Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran;

7. Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran

Funder

Faculty of Pharmacy, Zanjan University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

Reference23 articles.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献